FDA approves Humira maker AbbVie’s new rheumatoid arthritis drug

By

FDA approves Humira maker AbbVie's new rheumatoid arthritis drug

The U.S. Food and Drug Administration on Friday approved AbbVie’s new treatment for rheumatoid arthritis, a win for the drugmaker seeking to widen its portfolio.

Source: Business News –

MustHaves.LA a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for us to earn fees by linking to Amazon.com and affiliated sites.